Here we show, for the first time, spontaneous cortical spreading depolarization (CSD) events - the electrophysiological correlate of the migraine aura - in animals by using the first generated familial hemiplegic migraine type 3 (FHM3) transgenic mouse model. The mutant mice express L263V-mutated α1 subunits in voltage-gated NaV 1.1 sodium channels (Scn1aL263V ). CSDs consistently propagated from visual to motor cortex, recapitulating what has been shown in patients with migraine with aura. This model may be valuable for the preclinical study of migraine with aura and other diseases in which spreading depolarization is a prominent feature.
Here we show, for the first time, spontaneous cortical spreading depolarization (CSD) events - the electrophysiological correlate of the migraine aura - in animals by using the first generated familial hemiplegic migraine type 3 (FHM3) transgenic mouse model. The mutant mice express L263V-mutated α1 subunits in voltage-gated NaV 1.1sodium channels (Scn1aL263V ). CSDs consistently propagated from visual to motor cortex, recapitulating what has been shown in patients with migraine with aura. This model may be valuable for the preclinical study of migraine with aura and other diseases in which spreading depolarization is a prominent feature.
Cortical spreading depolarization (CSD) has been implicated in various human diseases, not only in migraine with aura and its monogenic subtype familial hemiplegic migraine, but also in stroke and traumatic brain injury.1 Most of the evidence linking CSD with migraine comes from animal studies, but until now CSD events, without exemption, need to be evoked by stimulating the cortex of the animal. The lack of evidence for spontaneous events in animals hampers the study of CSD initiation.FHM3, an autosomal dominant migraine with aura subtype with severe aura symptoms, is caused by specific missense mutations in the SCN1A gene that encodes the α1 subunit of voltage‐gated NaV1.1sodium channels.2 The overwhelming majority of mutations in SCN1A cause Dravet syndrome, a childhood epilepsy phenotype, due to loss of channel function.3 FHM3 mutations instead seem associated with gain of NaV1.1 channel properties, as was demonstrated in heterologous expression studies.4, 5, 6 The FHM3L263V mutation resulted in impaired channel inactivation, accelerated recovery from inactivation, and greater channel availability of the mutant channels in tsA‐201 cells.6To study in vivo effects of the L263V mutation, and assess whether mutant mice exhibit spontaneous CSD, we generated the first FHM3 knock‐in mouse model by introducing the mutation into the endogenous Scn1a gene using a CRISPR/Cas9 approach. We present the Scn1aL263Vmouse model as a promising mouse model to further the understanding of disease mechanisms in which spreading depolarizations are involved.
Methods
Generation of Scn1a
L263V mice
A 1.3 kb dsDNA fragment containing a C to G transition at nucleotide position 787 in exon 7, resulting in a leucine to valine (L263V) amino acid change, of the Scn1a gene was used as a template for CRISPR/Cas9‐mediated homologous recombination, and introduced in JM8 (C57BL/6J) embryonic stem cells. Clones carrying the correct mutation were injected in C57BL/6J blastocysts to generate chimeric mice. The L263V mutation was transmitted through the germline by breeding chimeric mice with C57BL/6J mice and the subsequent line was maintained on the same genetic background. As maintaining other Scn1a mutants on a 129/SvJ background increased survival,7 we also interbred our mutants with 129/SvJ mice. On either background success of breeding was greatly enhanced by feeding male heterozygous Scn1aL263Vmice chow that contained GS967 (8 mg/kg chow; Research Diets, New Brunswick, NJ), as previously used.8, 9 During the mating period, males were given standard chow, just as female wild‐type (WT) mice. Hence all experimental mice were exclusively exposed to standard chow. Experiments were approved by local and national ethical committees conforming to the recommendations of the European Communities Council Directive (2010/63/EU) and carried out in accordance with ARRIVE guidelines. For behavioral phenotyping, naïve Scn1aL263V and WT mice were videotaped from P21–P28 for 2 months or until death.
Surgery for electrophysiology
Prior to surgery, all surgical instruments and electrodes were disinfected with 70% ethanol. ECoG (silver balltips; 75 µm, AG5493; Advent Research Materials, Oxford, UK) or intracortical electrodes (75 µm platinum/iridium, PT6718) were implanted in Scn1aL263V (n = 15 and n = 9, respectively) and WT (n = 8 and n = 5, respectively) mice (P21–P28) under isoflurane anesthesia (4% for induction; 1.5% for maintenance) bilaterally in the primary visual cortex (V1; −3.5/2.0/0.5; mm relative to bregma; anterior, lateral, and ventral, respectively) and primary motor cortex (M1; +1.5/1.8/0.5). In a subset of animals (14/24 Scn1aL263V and 9/13 WT mice), an additional electrode was implanted in the right hippocampus (−2.2/1.5/1.7).In a further 8 Scn1aL263Vmice, epicranial electrodes were placed by thinning of the skull overlying V1 and M1, followed by attachment of silver ball tips using conductive carbon‐based glue (Anders Products, Melrose, MA).Electrical threshold for CSD was established by cortical stimulation in Scn1aL263V (n = 9) and WT (n = 10) mice. Bipolar stimulation electrodes were implanted bilaterally in caudal V1 (−3.8/2.3/0.5), with recording electrodes in rostral V1 (−2.5/2.4/0.5), M1, and the right hippocampus.
Data acquisition and analyses
Following surgery, animals were connected to a custom‐made 7‐channel system for continuous video‐EEG recordings. Data were acquired as described previously.10 CSD was defined as a transient negative DC‐shift of >5 mV measured at two locations with a delay, associated with a decrease in AC amplitude. Cortical DC‐shifts in only one electrode accompanied by decreased AC amplitude were never observed. DC‐recordings were inspected for CSDs during 2 weeks postoperatively, or until death of the animal. For all Scn1aL263Vmice, abnormal behavior, such as seizures, were studied for the whole recording period using AC‐recordings and video.For CSD induction, cathodal pulses of increasing intensities (1–5000 µC) were delivered every 3 min, until a CSD was observed, and propagation speed between electrodes in V1 and M1 was calculated. Two stimulations were performed per animal, at 24 and 48 h after surgery (once in either hemisphere), and threshold and propagation rate were averaged for analyses.Statistical testing was performed in Graphpad Prism (GraphPad Software, La Jolla, CA). A P‐value of <0.05 was considered significant.
Immunohistochemistry
Mice were perfused with PBS and 4% PFA. Brains were postfixed, cryoprotected, and coronally sectioned (20 µm) on a cryostat. Antigen retrieval in 10 mmol/L citrate buffer with 0.05% Tween was followed by blocking in 10% normal goat serum for 90 min and double‐labeling with rabbit anti‐Nav1.1 (1:200; Alomone Labs, Jerusalem, Israel) and mouse anti‐GAD67 (1:200; Millipore Sigma, St. Louis, MO) antibodies overnight at 4°C. Incubation in goat anti‐rabbit Cy2 (1:200) and goat anti‐mouse Cy3 (1:200; Jackson Immunoresearch, Cambridgeshire, UK) antibodies was performed for 2 h. Sections were mounted in medium containing 1 µL/mL Hoechst‐33258 and examined using confocal microscopy.
Results
CRISPR/Cas9‐mediated homologous recombination was used to introduce the humanFHM3L263V missense SCN1A mutation in the orthologous mouse gene, generating Scn1aL263Vmice (Fig. 1A). Cortical expression of NaV1.1 protein was observed, mostly in GABAergic interneurons, in WT and heterozygous Scn1aL263Vmice at P21 (Fig. 1E), and in WT, heterozygous, and homozygous Scn1aL263Vmice at P14 (Fig. 1F) with no overt difference between genotypes.
Figure 1
Generation, molecular characterization, and survival of Scn1a
L263V mice. (A) Genomic structure of the Scn1a allele and guide RNA used to introduce the L263V mutation in exon 7 (indicated by the arrowhead) and the electropherogram of the modified DNA sequence. (B) Sequencing analysis of RT‐PCR products from whole brain mRNA isolated from WT and heterozygous Scn1a
L263V mice. (C) Normalized expression of Scn1a mRNA in WT and Scn1a
L263V (Mut) mice. (D) Survival of naïve (not implanted) Scn1a
L263V mice on a C57BL/6J (B6; black) and mixed (50:50) C57BL/6J/129/SvJ (B6/129; grey) background was not significantly different (P = 0.152, Log‐rank test). Implanted C57BL/6J Scn1a
L263V mice (red) had a significantly decreased survival (P < 0.001, Log‐rank test), whereas no early mortality was observed in implanted WT mice (n = 9; not shown). (E,F) Immunofluorescence of NaV1.1 protein in the primary visual cortex of P21 WT and heterozygous Scn1a
L263V (E) and P14 WT, heterozygous and homozygous Scn1a
L263V (F) mice showed a strong overlap in expression with GAD67, a marker for inhibitory interneurons (white arrows indicating double‐labeled neurons) that was similar between genotypes. Scale bars, 20 µm.
Generation, molecular characterization, and survival of Scn1aL263Vmice. (A) Genomic structure of the Scn1a allele and guide RNA used to introduce the L263V mutation in exon 7 (indicated by the arrowhead) and the electropherogram of the modified DNA sequence. (B) Sequencing analysis of RT‐PCR products from whole brain mRNA isolated from WT and heterozygous Scn1aL263Vmice. (C) Normalized expression of Scn1a mRNA in WT and Scn1aL263V (Mut) mice. (D) Survival of naïve (not implanted) Scn1aL263Vmice on a C57BL/6J (B6; black) and mixed (50:50) C57BL/6J/129/SvJ (B6/129; grey) background was not significantly different (P = 0.152, Log‐rank test). Implanted C57BL/6J Scn1aL263Vmice (red) had a significantly decreased survival (P < 0.001, Log‐rank test), whereas no early mortality was observed in implanted WT mice (n = 9; not shown). (E,F) Immunofluorescence of NaV1.1 protein in the primary visual cortex of P21 WT and heterozygous Scn1aL263V (E) and P14 WT, heterozygous and homozygous Scn1aL263V (F) mice showed a strong overlap in expression with GAD67, a marker for inhibitory interneurons (white arrows indicating double‐labeled neurons) that was similar between genotypes. Scale bars, 20 µm.
Survival of Scn1a
L263V mice
Heterozygous Scn1aL263Vmice died at juvenile to young adult age, irrespective of the genetic background (C57BL/6J or mixed (50:50) C57BL/6J/129/SvJ) (Fig. 1D). Video recordings of both naïve (n = 11; 8 females) and implanted (n = 24; 17 females) animals revealed that fatality was preceded by limited abnormal behavior lasting 1–14 sec characterized by hindlimb jerks and/or tonic hindlimb extension sometimes preceded by sudden wild running, or occurred directly from sleep (n = 3). No seizure‐related or other abnormal behaviors were observed over the recording period preceding death.
Spontaneous and induced CSD in Scn1a
L263V mice
In a subset of Scn1aL263Vmice (9/24; 6 females; ECoG in 5/9, intracortical in 4/9), a total of 50 spontaneous CSD events were observed in 601 h of recording (compared to 0/13 WT mice; χ
2(1) = 6.442, P = 0.011). The survival time of mice with spontaneous CSDs was not different from mice without CSDs (67 ± 24 h versus 108 ± 35 h, respectively; P = 0.327, unpaired t‐test). In animals with more than one CSD (n = 6; range 2–33 CSDs), time between consecutive CSDs ranged from 28 min–31.2 h. CSD events generally occurred in isolation; only one CSD event consisted of 2 DC‐shifts in each cortical electrode separated by approximately 3 min. Notably, all CSDs spread from V1 to M1 (Fig. 2A and B). In 6/9 mice with spontaneous CSDs, hippocampal DC‐potential was measured. Spread of CSDs to the ipsilateral hippocampus was observed in only one animal (Fig. 2B). In 3/9 animals with a hippocampal electrode, downward spikes of moderate amplitude (0.5–1.5 mV) were observed most often in V1, sometimes in M1, but never in hippocampus. These spikes occurred every few seconds, had a duration of 20–50 msec, and were not associated with behavioral abnormalities. M1, V1, and hippocampal recordings did not reveal seizure bursts during the fatal event or preceding recording period (total recording time of 2228 h, n = 24; 17 females). No overt CSD‐related behavioral abnormalities, including previously reported wet dog shakes or freezing behavior,11 were observed. A subset of CSDs occurred during sleep (21/50) and were accompanied by awakening of the animal (9/21), roughly coinciding with spread to M1 (example in Fig. 2B).
Figure 2
Spontaneous cortical spreading depolarization (CSD) in Scn1a
L263V mice with propagation from visual to motor cortex. (A and B) Examples of a spontaneous CSD during wakefulness in an Scn1a
L263V mouse, without evidence of spread to the ipsilateral hippocampus (HC) (A) and during sleep, with spread to the ipsilateral HC (B) (M1 = primary motor cortex; V1 = primary visual cortex). In the example in B, the animal awoke during the CSD (indicated by an asterisk), but no overt abnormal behavior was observed. (C) Propagation rate of spontaneous CSDs occurring >24 h following surgery. Every symbol represents a single CSD, grouped per animal (squares represent males, total n = 21 CSDs in 6 mice). (D) Example of a spontaneous CSD detected by epicranial electrodes in an Scn1a
L263V mouse. (E) Incidence of spontaneous CSDs recorded with ECoG, intracortical or epicranial electrodes. Each row represents one mouse, with individual CSDs indicated by black dots and death indicated by a gray cross. With respect to the time since surgery, CSD incidence was similar between the first and second half of recordings (26 and 27 CSDs, respectively). Note that epicranial recordings were not included in the analysis of CSD propagation speed (C), as onset of the DC‐shift appeared more gradual. For time series of V1 AC recordings (A,B,D) a bandpass filter of 0.5–100 Hz was used.
Spontaneous cortical spreading depolarization (CSD) in Scn1aL263Vmice with propagation from visual to motor cortex. (A and B) Examples of a spontaneous CSD during wakefulness in an Scn1aL263Vmouse, without evidence of spread to the ipsilateral hippocampus (HC) (A) and during sleep, with spread to the ipsilateral HC (B) (M1 = primary motor cortex; V1 = primary visual cortex). In the example in B, the animal awoke during the CSD (indicated by an asterisk), but no overt abnormal behavior was observed. (C) Propagation rate of spontaneous CSDs occurring >24 h following surgery. Every symbol represents a single CSD, grouped per animal (squares represent males, total n = 21 CSDs in 6 mice). (D) Example of a spontaneous CSD detected by epicranial electrodes in an Scn1aL263Vmouse. (E) Incidence of spontaneous CSDs recorded with ECoG, intracortical or epicranial electrodes. Each row represents one mouse, with individual CSDs indicated by black dots and death indicated by a gray cross. With respect to the time since surgery, CSD incidence was similar between the first and second half of recordings (26 and 27 CSDs, respectively). Note that epicranial recordings were not included in the analysis of CSD propagation speed (C), as onset of the DC‐shift appeared more gradual. For time series of V1 AC recordings (A,B,D) a bandpass filter of 0.5–100 Hz was used.Although absence of spontaneous CSD in WT mice suggests that this phenomenon is specific to Scn1aL263Vmice, we additionally tested whether spontaneous CSDs occurred in the absence of cortical damage induced by implantation of intracortical and/or ECoG electrodes. To this end, we measured DC‐potential in Scn1aL263Vmice using epicranial electrodes that did not penetrate the skull. In 2/8 chronically recorded Scn1aL263Vmice, 3 CSDs were detected in 146 h of recording (Fig. 2D and E).Cortical cathodal stimulation of V1 was performed in a separate group of freely behaving mice (n = 9 Scn1aL263V, 5 females; n = 10 WT, 4 females). CSD threshold was significantly lower in Scn1aL263Vmice than in WT littermates, whereas no difference was observed for propagation rate (Fig. 3).
Figure 3
Reduced threshold for cortical spreading depolarization (CSD) induced by electrical stimulation in freely behaving Scn1a
L263V mice. (A) Top view of experimental approach for electrical stimulation of the visual cortex (Stim; M1 = primary motor cortex; V1 = primary visual cortex). (B) Example of DC‐signal in primary motor cortex of a WT and Scn1a
L263V mouse, showing that more stimulations of increased intensity (arrowheads) were required to induce CSD in WT mice. Group analyses showed a reduced electrical threshold for CSD in Scn1a
L263V mice (*P < 0.001, Mann–Whitney test), while CSD propagation rate was not different (P = 0.29, Welch’s t‐test). Squares represent males.
Reduced threshold for cortical spreading depolarization (CSD) induced by electrical stimulation in freely behaving Scn1aL263Vmice. (A) Top view of experimental approach for electrical stimulation of the visual cortex (Stim; M1 = primary motor cortex; V1 = primary visual cortex). (B) Example of DC‐signal in primary motor cortex of a WT and Scn1aL263Vmouse, showing that more stimulations of increased intensity (arrowheads) were required to induce CSD in WT mice. Group analyses showed a reduced electrical threshold for CSD in Scn1aL263Vmice (*P < 0.001, Mann–Whitney test), while CSD propagation rate was not different (P = 0.29, Welch’s t‐test). Squares represent males.
Discussion
Investigation into the mechanisms involved in initiation of CSD events is hampered by the fact that such events need to be evoked as there is no animal model, yet, that shows spontaneous occurrence of CSD in metabolically intact tissue. Here, we report that mice expressing the humanSCN1AL263V mutation, that was shown to cause FHM3 in humans, exhibit spontaneous CSDs that propagate from visual to motor cortex.Functional consequences of FHM3‐related SCN1A mutations in transfected cells indicate an overall gain of function of NaV1.1 channels.4, 5, 6 This sharply contrasts with the loss of function observed with mutations causing Dravet syndrome, resulting in loss of NaV1.1 expression predominantly affecting GABAergic interneurons.7, 12, 13, 14 In mice, this loss of function results in spontaneous seizures and large‐amplitude interictal spikes, which we did not observe in Scn1aL263Vmice. As NaV1.1 is predominantly localized in inhibitory interneurons,7, 14 the present data suggest that the prominent CSD phenotype in Scn1aL263Vmice results from hyperexcitable cortical inhibitory interneurons. This mechanism seems counterintuitive in light of reports that GABA‐A receptor activation could inhibit, not facilitate, CSD.15, 16, 17 Still, a recent in silico study indeed suggested that intense firing of inhibitory interneurons may induce CSD, because of accumulation of extracellular potassium.18 Of note, increased sodium currents have also been reported in excitatory neurons of loss‐of‐function Scn1a mutants19 and increased persistent sodium currents, which may contribute to CSD20 have been reported in transfected cells that expressed SCN1A mutations associated with Dravet syndrome21 and FHM3.6 Clearly, the cellular substrate underlying CSD susceptibility in Scn1aL263Vmice remains to be determined.Unexpectedly, all Scn1aL263Vmice died prematurely with peak mortality between P21–35. Contrary to previous studies on loss‐of‐function Scn1a mutants,7, 22 genetic background, that is, maintaining the mutation on either a pure C57BL/6J or the mixed (50:50) C57BL/6J/129/SvJ background, had no significant impact on survival of Scn1aL263Vmice. Timing of peak mortality, however, seems to overlap with that of loss‐of‐function Scn1a mutants.23 This may be related to a developmental peak in NaV1.1 expression in this age range.14 In addition, spreading depolarization susceptibility is particularly high in this developmental time window24, 25 and was found to induce lethal apnea in an FHM1 mouse model.10, 26 However, as death is seizure‐related in FHM1 mutants10, 26 and loss‐of‐function Scn1a mutants,23 the mechanism of death in Scn1aL263Vmice may be different.Notably, in Scn1aL263Vmice, all spontaneous CSDs spread from visual to motor cortex, which is in line with rare observations of visual aura features from neuroimaging in patients with migraine with aura,27 commonly attributed to the occurrence of CSD. Together, these data indicate that Scn1aL263Vmice may serve as a valuable model to study mechanisms underlying initiation of spreading depolarizations, which may be relevant to disorders including migraine with aura, stroke and traumatic brain injury.
Author Contributions
N.A.J. conceptualized the study, designed and performed experiments, analyzed the data, wrote, and revised the manuscript. A.D. performed histology and confocal microscopy. M.M.L.L. maintained the mouse colony and performed molecular analyses. C.B. performed CRISPR/Cas9‐mediated mutagenesis and molecular analyses. E.A.T. advised on experiments and revised the manuscript. A.M.J.M.v.d.M. conceptualized the study, advised on experiments and revised the manuscript.
Authors: Chao Tai; Yasuyuki Abe; Ruth E Westenbroek; Todd Scheuer; William A Catterall Journal: Proc Natl Acad Sci U S A Date: 2014-07-14 Impact factor: 11.205
Authors: Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall Journal: Nat Neurosci Date: 2006-08-20 Impact factor: 24.884
Authors: Akshitkumar M Mistry; Christopher H Thompson; Alison R Miller; Carlos G Vanoye; Alfred L George; Jennifer A Kearney Journal: Neurobiol Dis Date: 2014-01-14 Impact factor: 5.996
Authors: Kristopher M Kahlig; Thomas H Rhodes; Michael Pusch; Tobias Freilinger; José M Pereira-Monteiro; Michel D Ferrari; Arn M J M van den Maagdenberg; Martin Dichgans; Alfred L George Journal: Proc Natl Acad Sci U S A Date: 2008-07-09 Impact factor: 11.205
Authors: Moran Rubinstein; Ruth E Westenbroek; Frank H Yu; Christina J Jones; Todd Scheuer; William A Catterall Journal: Neurobiol Dis Date: 2014-10-02 Impact factor: 5.996
Authors: Nico A Jansen; Maarten Schenke; Rob A Voskuyl; Roland D Thijs; Arn M J M van den Maagdenberg; Else A Tolner Journal: J Neurosci Date: 2019-10-18 Impact factor: 6.167
Authors: Martin Dichgans; Tobias Freilinger; Gertrud Eckstein; Elena Babini; Bettina Lorenz-Depiereux; Saskia Biskup; Michel D Ferrari; Jürgen Herzog; Arn M J M van den Maagdenberg; Michael Pusch; Tim M Strom Journal: Lancet Date: 2005 Jul 30-Aug 5 Impact factor: 79.321
Authors: Brandon Foreman; Hyunjo Lee; David O Okonkwo; Anthony J Strong; Clemens Pahl; Lori A Shutter; Jens P Dreier; Laura B Ngwenya; Jed A Hartings Journal: Neurocrit Care Date: 2022-02-16 Impact factor: 3.532
Authors: Patrick D Parker; Pratyush Suryavanshi; Marcello Melone; Punam A Sawant-Pokam; Katelyn M Reinhart; Dan Kaufmann; Jeremy J Theriot; Arianna Pugliese; Fiorenzo Conti; C William Shuttleworth; Daniela Pietrobon; K C Brennan Journal: Neuron Date: 2020-12-14 Impact factor: 17.173
Authors: Eva Auffenberg; Ulrike Bs Hedrich; Raffaella Barbieri; Daniela Miely; Bernhard Groschup; Thomas V Wuttke; Niklas Vogel; Philipp Lührs; Ilaria Zanardi; Sara Bertelli; Nadine Spielmann; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Michael Pusch; Martin Dichgans; Holger Lerche; Paola Gavazzo; Nikolaus Plesnila; Tobias Freilinger Journal: J Clin Invest Date: 2021-11-01 Impact factor: 14.808